FDA Approves CELMoD Combination Regimen for Pretreated Multiple Myeloma
FDA Approves CELMoD Combination Regimen for Pretreated Multiple Myeloma The ASCO Post
Regulatory Approvals
FDA approves new Alzheimer’s PET imaging agent from Lantheus
FDA approves new Alzheimer’s PET imaging agent from Lantheus Radiology Business
FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup
FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup NeurologyLive
US FDA approves Lantheus’ brain-imaging agent for Alzheimer’s assessment
US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment Reuters
FDA Clears Denifanstat Phase 3 Trial for Moderate to Severe Acne
FDA Clears Denifanstat Phase 3 Trial for Moderate to Severe Acne The Clinical Trial Vanguard